1. Home
  2. CNTB vs CRT Comparison

CNTB vs CRT Comparison

Compare CNTB & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • CRT
  • Stock Information
  • Founded
  • CNTB 2012
  • CRT 1991
  • Country
  • CNTB United States
  • CRT United States
  • Employees
  • CNTB N/A
  • CRT N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • CRT Oil & Gas Production
  • Sector
  • CNTB Health Care
  • CRT Energy
  • Exchange
  • CNTB Nasdaq
  • CRT Nasdaq
  • Market Cap
  • CNTB 55.2M
  • CRT 64.0M
  • IPO Year
  • CNTB 2021
  • CRT 1992
  • Fundamental
  • Price
  • CNTB $0.57
  • CRT $12.26
  • Analyst Decision
  • CNTB Strong Buy
  • CRT
  • Analyst Count
  • CNTB 1
  • CRT 0
  • Target Price
  • CNTB $8.00
  • CRT N/A
  • AVG Volume (30 Days)
  • CNTB 50.6K
  • CRT 33.6K
  • Earning Date
  • CNTB 03-31-2025
  • CRT 01-01-0001
  • Dividend Yield
  • CNTB N/A
  • CRT 8.11%
  • EPS Growth
  • CNTB N/A
  • CRT N/A
  • EPS
  • CNTB N/A
  • CRT 0.95
  • Revenue
  • CNTB $26,033,000.00
  • CRT $6,623,430.00
  • Revenue This Year
  • CNTB $997.61
  • CRT N/A
  • Revenue Next Year
  • CNTB N/A
  • CRT N/A
  • P/E Ratio
  • CNTB N/A
  • CRT $13.92
  • Revenue Growth
  • CNTB N/A
  • CRT N/A
  • 52 Week Low
  • CNTB $0.55
  • CRT $8.88
  • 52 Week High
  • CNTB $2.66
  • CRT $14.98
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 26.20
  • CRT 61.40
  • Support Level
  • CNTB $0.80
  • CRT $11.60
  • Resistance Level
  • CNTB $0.84
  • CRT $12.43
  • Average True Range (ATR)
  • CNTB 0.08
  • CRT 0.52
  • MACD
  • CNTB -0.02
  • CRT 0.15
  • Stochastic Oscillator
  • CNTB 6.34
  • CRT 61.91

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: